Hahn Capital Management LLC increased its holdings in Genpact Limited (NYSE:G - Free Report) by 48.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 238,577 shares of the business services provider's stock after buying an additional 77,341 shares during the period. Genpact accounts for 4.5% of Hahn Capital Management LLC's holdings, making the stock its 10th largest position. Hahn Capital Management LLC owned 0.14% of Genpact worth $10,247,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Jensen Investment Management Inc. raised its holdings in Genpact by 6.4% in the 3rd quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider's stock valued at $7,449,000 after acquiring an additional 11,410 shares in the last quarter. Stifel Financial Corp acquired a new position in Genpact in the third quarter valued at about $1,197,000. Blue Trust Inc. lifted its position in Genpact by 8.7% during the fourth quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock worth $217,000 after purchasing an additional 441 shares during the period. Burney Co. grew its stake in Genpact by 242.8% during the fourth quarter. Burney Co. now owns 130,798 shares of the business services provider's stock worth $5,618,000 after buying an additional 92,641 shares in the last quarter. Finally, KBC Group NV bought a new position in Genpact in the 4th quarter valued at about $298,000. 96.03% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
G has been the subject of a number of recent analyst reports. Needham & Company LLC upped their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their target price for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho lifted their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and boosted their price target for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Robert W. Baird raised their price objective on Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research note on Friday, November 8th. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $48.44.
Read Our Latest Stock Analysis on G
Genpact Trading Down 1.0 %
Shares of NYSE:G traded down $0.53 during midday trading on Monday, hitting $52.69. 1,577,501 shares of the stock were exchanged, compared to its average volume of 1,559,895. The business's 50-day moving average price is $48.00 and its 200 day moving average price is $43.46. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The stock has a market capitalization of $9.29 billion, a price-to-earnings ratio of 18.55, a P/E/G ratio of 1.84 and a beta of 1.20.
Genpact (NYSE:G - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, March 11th. This is a boost from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 1.29%. Genpact's dividend payout ratio is 23.94%.
Insider Buying and Selling
In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the firm's stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the transaction, the chief executive officer now owns 267,404 shares of the company's stock, valued at $11,926,218.40. This trade represents a 4.84 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by insiders.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report